4.6 Article

The Immunophilin-Like Protein XAP2 Is a Negative Regulator of Estrogen Signaling through Interaction with Estrogen Receptor α

Journal

PLOS ONE
Volume 6, Issue 10, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0025201

Keywords

-

Funding

  1. Consortorium for Research into Nuclear Receptors in Development and Aging Integrated Project [LSHM-CT-2005-018652]
  2. CASCADE Network of Excellence [FOOD-CT-2004-506319 CASCADE]

Ask authors/readers for more resources

XAP2 (also known as aryl hydrocarbon receptor interacting protein, AIP) is originally identified as a negative regulator of the hepatitis B virus X-associated protein. Recent studies have expanded the range of XAP2 client proteins to include the nuclear receptor family of transcription factors. In this study, we show that XAP2 is recruited to the promoter of ER alpha regulated genes like the breast cancer marker gene pS2 or GREB1 and negatively regulate the expression of these genes in MCF-7 cells. Interestingly, we show that XAP2 downregulates the E(2)-dependent transcriptional activation in an estrogen receptor (ER) isoform-specific manner: XAP2 inhibits ER alpha but not ER beta-mediated transcription. Thus, knockdown of intracellular XAP2 levels leads to increased ER alpha activity. XAP2 proteins, carrying mutations in their primary structures, loose the ability of interacting with ER alpha and can no longer regulate ER target gene transcription. Taken together, this study shows that XAP2 exerts a negative effect on ER alpha transcriptional activity and may thus prevent ER alpha-dependent events.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available